Clinical Trials
18 trialsNCT03447470 2025-01-29
Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies
Redx Pharma Ltd
Phase 1 Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT01621568 2024-09-24
Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01325441 2023-11-15
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Sumitomo Pharma America, Inc.
Phase 1/2 Completed
NCT00591981 2023-06-05
TOGA
University of Wisconsin, Madison
Completed
NCT03517488 2022-12-01
DUET-2
Xencor, Inc.
Phase 1 Completed
NCT03023319 2022-06-14
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Augusta University
Phase 1 Completed
NCT02420691 2020-10-30
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00921739 2020-04-02
ESIMRT
Duke University
Phase 1 Completed
NCT01364727 2019-04-16
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
Phase 2 Completed
NCT01794676 2017-06-16
MEN1
Jersey Shore University Medical Center
Completed
NCT03078699 2017-03-13
Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment
Third Military Medical University
Phase NA Completed
NCT02233842 2016-09-12
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
National Institutes of Health Clinical Center (CC)
Completed
NCT01312324 2016-04-20
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Samsung Medical Center
Phase 2 Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT01163552 2014-06-13
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
St. Luke's-Roosevelt Hospital Center
Phase 2 Completed
NCT00369889 2014-06-03
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
Phase 2 Completed
NCT00990535 2009-10-07
HIDONET
Federico II University
Phase 2 Completed